Next Article in Journal
Calcium Channel Blockers as Tocolytics: Principles of Their Actions, Adverse Effects and Therapeutic Combinations
Next Article in Special Issue
Loss of Response to Long-Term Infliximab Therapy in Children with Crohn’s Disease
Previous Article in Journal
FedExosomes: Engineering Therapeutic Biological Nanoparticles that Truly Deliver
Previous Article in Special Issue
Advances in Mammalian Cell Line Development Technologies for Recombinant Protein Production
Pharmaceuticals 2013, 6(5), 681-688; doi:10.3390/ph6050681

Notes on Article Versions

Action Date Notes Link
article pdf uploaded. 14 May 2013 12:18 CEST Version of Record http://www.mdpi.com/1424-8247/6/5/681/pdf
article xml file uploaded 13 September 2013 17:19 CEST Original file http://www.mdpi.com/1424-8247/6/5/681/xml
article html file updated 13 September 2013 17:19 CEST Original file -
article html file updated 17 June 2015 09:17 CEST Update http://www.mdpi.com/1424-8247/6/5/681/html
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert